Raffaele Parrozzani

Dr. Raffaele Parrozzani

University of Padova, Padova, Veneto, Italy
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Retina
Verified
Journal Article
Closed access
SVStela Vujosevic
Stela Vujosevic
SBSilvia Bini
Silvia Bini
TTTommaso Torresin
Tommaso Torresin
MBMarianna Berton
Marianna Berton
GMGiulia Midena
Giulia Midena
EMEdoardo Midena
Edoardo Midena
To evaluate hyperreflective retinal spots (HRS), in normal subjects and diabetic patients without and with macular edema (diabetic macular edema, DME), on linear B-scans and corresponding en face image of spectral-domain optical coherence tomography. Retrospective evaluation of images of 54 eyes/subjects (16 normal subjects, 19 diabetic patients without DME, and 19 with DME). On horizontal B-scan spectral-domain optical coherence tomography, passing through the center of the fovea, the following characteristics of HRS were evaluated: location (inner retina or outer retina), size (≤30 or >30 μm), reflectivity (similar to nerve fiber layer or to retinal pigment epithelium–Bruch complex), and presence or absence of back shadowing. On en face spectral-domain optical coherence tomography, the following patterns were evaluated: 1) isolated HRS (not corresponding to any visible lesion); 2) HRS corresponding to a segment of retinal capillary or microaneurysm wall; and 3) HRS corresponding to hard exudate. All gradings were performed twice by two graders in a masked fashion. Size ≤30 μm, reflectivity similar to nerve fiber layer, and absence of back shadowing were associated with absence of vessels or any other lesion on en face image (P = 0.0001 for all). Size >30 μm, reflectivity similar to retinal pigment epithelium–Bruch complex, presence of back shadowing, and location in the outer retina were all associated with presence of hard exudate on en face imaging (P < 0.0001 for all). Multiple logistic regression analysis showed that HRS present in the inner retina (P < 0.0001), size >30 μm (P = 0.0029), and presence of back shadowing (P < 0.0001) are directly associated with presence of microaneurysms on en face image. Intragrader and intergrader repeatability were excellent for all evaluations. Hyperreflective retinal spots ≤30 μm, reflectivity similar to nerve fiber layer, and absence of back shadowing may represent activated microglial cells; HRS >30 μm, reflectivity similar to retinal pigment epithelium–Bruch complex, presence of back shadowing, and location in the outer retina may represent hard exudate; HRS >30 μm, presence of back shadowing, and location in the inner retina may represent microaneurysms. These hypotheses may be tested in further studies.

24 October 2016 in Acta Ophthalmologica
Verified
Journal Article
Closed access
PDF file
SVStela Vujosevic
Stela Vujosevic
TTTommaso Torresin
Tommaso Torresin
SBSilvia Bini
Silvia Bini
ECEnrica Convento
Enrica Convento
EPElisabetta Pilotto
Elisabetta Pilotto
Edoardo MidenaEdoardo Midena
Edoardo Midena

7 August 2010 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
Raffaele ParrozzaniRaffaele Parrozzani
Raffaele Parrozzani
DLDaniela Lazzarini
Daniela Lazzarini
EAErnesto Alemany-Rubio
Ernesto Alemany-Rubio
FUFrancesca Urban
Francesca Urban
EMEdoardo Midena
Edoardo Midena
Background/aims The aim of this study was to evaluate the long-term corneal toxicity of topical chemotherapy with 1% 5-fluorouracil (5-FU) as a sole or adjuvant treatment of ocular surface squamous neoplasia (OSSN). Methods Forty-one consecutive cases of OSSN were included in this prospective study. Patients underwent topical chemotherapy with 1% 5-FU four times/day for 4 weeks (one course). Adjunctive courses were repeated until clinical and cytological tumour regression. Clinical confocal microscopy was used to check for 5-FU long-term corneal toxicity. Results Mean follow-up was 89.7±14.4 months (range 63–122 months). Twenty-two patients (53.7%) underwent topical 5-FU as a sole treatment, and 19 patients (46.3%) as adjuvant and/or debulking therapy. The mean number of 5-FU cycles was 1.9 (range 1–5 cycles). Three tumours (7.3%) treated with 5-FU alone recurred during follow-up. Recurrences were successfully treated with additional 5-FU courses. Clinical confocal microscopy showed no long-term difference between the treated eye and fellow (control) eye in: endothelial cells count, pleomorphism and polymegatism, anterior stromal keratocyte density, sub-basal nerve plexus fibre number, density, and beadings and central cornea epithelium thickness (p=NS). Conclusion Topical 5-FU, as a sole or combined therapy, must be considered a long-term safe and effective treatment for patients affected by OSSN.

9 December 2016 in British Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
Raffaele ParrozzaniRaffaele Parrozzani
Raffaele Parrozzani
LFLuisa Frizziero
Luisa Frizziero
STSara Trainiti
Sara Trainiti
ITIlaria Testi
Ilaria Testi
GMGiacomo Miglionico
Giacomo Miglionico
Edoardo MidenaEdoardo Midena
Edoardo Midena
Aims To report long-term clinical outcome of topical 1% 5-fluoruracil (5-FU) as a sole treatment of ocular surface squamous neoplasia (OSSN). Methods 41 patients affected by OSSN were included. Each patient underwent full ophthalmological examination at baseline, with cytological or histological confirmation. Patients were treated by topical chemotherapy with 1% 5-FU four times a day for 4 weeks. One course was defined as 4 weeks of topical chemotherapy. Adjunctive courses were administered after 1 month of chemotherapy-free interval. Results Mean follow-up was 105±32 months (range 60–171 months). Complete tumour regression was achieved in 34 cases (83%) after a mean of 1.5 courses (range, 1–3 courses). Univariate analysis revealed that complete response was significantly related to tumour thickness 1.5 mm (p=0.045) and multifocality (p=0.023) were correlated with incomplete tumour response. Transient and reversible low-to-mild local side effects were documented in 19 (48%) eyes. Conclusion Topical 5-FU, as a sole therapy, is a long-term safe and effective treatment for patients affected by preinvasive OSSN and for a limited proportion (50%) of invasive OSSN.

1 April 2016 in Ophthalmology
Verified
Journal Article
Closed access
RARana'A T. Al-Jamal
Rana'A T. Al-Jamal
NCNathalie Cassoux
Nathalie Cassoux
LDLaurence Desjardins
Laurence Desjardins
BDBertil Damato
Bertil Damato
LKLazaros Konstantinidis
Lazaros Konstantinidis
TKTero T. Kivelä
Tero T. Kivelä

14 October 2014 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
CGCatia Gambato
Catia Gambato
ELEvelyn Longhin
Evelyn Longhin
ACAnton Giulio Catania
Anton Giulio Catania
DLDaniela Lazzarini
Daniela Lazzarini
Raffaele ParrozzaniRaffaele Parrozzani
Raffaele Parrozzani
Edoardo MidenaEdoardo Midena
Edoardo Midena